NR3C1 and memory impairment: Our recent study suggested that microinjection of Aβ1–42 induced memory impairment peaked at 2 months, which is associated with HPA axis dysfunction such as enhancement in serum corticosterone (CORT) level, corticotropin-releasing factor (CRF) expression, and GR expression in the brain.